Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
3,4-Methylenedioxy methamphetamine, synthetic cathinones and psychedelics: From recreational to novel psychotherapeutic drugs.
López-Arnau R, Camarasa J, Carbó ML, Nadal-Gratacós N, Puigseslloses P, Espinosa-Velasco M, Urquizu E, Escubedo E, Pubill D. López-Arnau R, et al. Among authors: carbo ml. Front Psychiatry. 2022 Oct 3;13:990405. doi: 10.3389/fpsyt.2022.990405. eCollection 2022. Front Psychiatry. 2022. PMID: 36262632 Free PMC article. Review.
Metabolomics predicts the pharmacological profile of new psychoactive substances.
Olesti E, De Toma I, Ramaekers JG, Brunt TM, Carbó ML, Fernández-Avilés C, Robledo P, Farré M, Dierssen M, Pozo ÓJ, de la Torre R. Olesti E, et al. Among authors: carbo ml. J Psychopharmacol. 2019 Mar;33(3):347-354. doi: 10.1177/0269881118812103. Epub 2018 Nov 19. J Psychopharmacol. 2019. PMID: 30451567
Dose-Response Pharmacological Study of Mephedrone and Its Metabolites: Pharmacokinetics, Serotoninergic Effects, and Impact of CYP2D6 Genetic Variation.
Olesti E, Farré M, Carbó ML, Papaseit E, Perez-Mañá C, Torrens M, Yubero-Lahoz S, Pujadas M, Pozo ÓJ, de la Torre R. Olesti E, et al. Among authors: carbo ml. Clin Pharmacol Ther. 2019 Sep;106(3):596-604. doi: 10.1002/cpt.1417. Epub 2019 Apr 8. Clin Pharmacol Ther. 2019. PMID: 30815856 Clinical Trial.
Changes in CYP1A2 activity in humans after 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) administration using caffeine as a probe drug.
Yubero-Lahoz S, Pardo R, Farre M, Mathuna BÓ, Torrens M, Mustata C, Perez-Mañá C, Langohr K, Carbó ML, de la Torre R. Yubero-Lahoz S, et al. Among authors: carbo ml. Drug Metab Pharmacokinet. 2012;27(6):605-13. doi: 10.2133/dmpk.dmpk-12-rg-032. Epub 2012 May 22. Drug Metab Pharmacokinet. 2012. PMID: 22673010 Free article.
18 results